TEVASTIM Trademark

Trademark Overview

On Thursday, February 23, 2006, a trademark application was filed for TEVASTIM with the United States Patent and Trademark Office. The USPTO has given the TEVASTIM trademark a serial number of 78821496. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 27, 2015. This trademark is owned by TEVA Pharmaceutical Industries Ltd.. The TEVASTIM trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, filgastrim, a recombinant human GCSF (granulocyte colony-stimulating factor) for use in the treatment of chemotherapy related neutropenia
tevastim

General Information

Serial Number78821496
Word MarkTEVASTIM
Filing DateThursday, February 23, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 27, 2015
Registration Number3492680
Registration DateTuesday, August 26, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 10, 2008

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, filgastrim, a recombinant human GCSF (granulocyte colony-stimulating factor) for use in the treatment of chemotherapy related neutropenia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 27, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTEVA Pharmaceutical Industries Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJerusalem 91010
IL
Party NameTEVA Pharmaceutical Industries Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJerusalem 91010
IL
Party NameTEVA Pharmaceutical Industries Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Friday, March 27, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, August 26, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, June 10, 2008PUBLISHED FOR OPPOSITION
Wednesday, May 21, 2008NOTICE OF PUBLICATION
Friday, March 14, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 16, 2008ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Saturday, February 16, 20081(B) BASIS DELETED; NEW BASIS REQUESTED
Wednesday, February 6, 2008NOTICE OF ALLOWANCE CANCELLED
Friday, February 15, 2008PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, February 14, 2008ASSIGNED TO PETITION STAFF
Monday, February 11, 2008PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Monday, February 11, 2008PAPER RECEIVED
Wednesday, February 6, 2008EXTENSION 2 GRANTED
Wednesday, February 6, 2008EXTENSION 2 FILED
Wednesday, February 6, 2008TEAS EXTENSION RECEIVED
Tuesday, September 4, 2007EXTENSION 1 GRANTED
Tuesday, September 4, 2007EXTENSION 1 FILED
Tuesday, September 4, 2007TEAS EXTENSION RECEIVED
Tuesday, March 20, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 26, 2006PUBLISHED FOR OPPOSITION
Wednesday, December 6, 2006NOTICE OF PUBLICATION
Friday, November 3, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 3, 2006ASSIGNED TO LIE
Friday, October 27, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 26, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 23, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 23, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 27, 2006FINAL REFUSAL E-MAILED
Wednesday, September 27, 2006FINAL REFUSAL WRITTEN
Monday, September 25, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 22, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 22, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 18, 2006NON-FINAL ACTION E-MAILED
Friday, August 18, 2006NON-FINAL ACTION WRITTEN
Monday, August 14, 2006ASSIGNED TO EXAMINER
Wednesday, March 1, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

tevastim factor stimulating treatment chemotherapy neutropenia related colony granulocyte namely preparations